Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT
Cocrystal Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.85M | -17.5M | -18.7M | -17.93M | -16.75M | -17.98M | -18.02M | -19.56M | -39.82M | -38.84M | -38.02M | -36.26M | -15.65M | -14.19M | -11.99M | -10.72M | -10.4M |
Depreciation & Amortization | 367K | 377K | -1.42M | -1.35M | -1.46M | -1.39M | 412K | 402K | 445K | 388K | 336K | 288K | 191K | 190K | 187K | 181K | 172K |
Stock-Based Compensation | 568K | 643K | 716K | 636K | 667K | 801K | 802K | 845K | 907K | 855K | 918K | 907K | 744K | 724K | 701K | 733K | 774K |
Other Working Capital | 226.74K | 483.74K | -12.76K | 1.73M | 712.66K | -1.51M | -1.83M | -5.86M | -4.1M | -2.08M | -1.63M | 63.38M | 62.57M | 94.75M | 93.44M | 32.22M | 32.09M |
Other Non-Cash Items | -238.32K | 984.68K | 916.03K | 919.69K | 972.67K | -306.33K | -227K | -222K | 18.88M | 18.87M | 18.88M | 18.88M | -208K | -195K | -192K | -275K | -181K |
Deferred Income Tax | n/a | n/a | 2.38M | 2.38M | 2.38M | 2.38M | n/a | n/a | n/a | n/a | -22K | -39K | -48K | -49K | -2K | -26K | 26K |
Change in Working Capital | 976.32K | 237.32K | 1.15M | 2.87M | -188.64K | 2.29M | 801K | -3.93M | -1.05M | -2.71M | -1.55M | 267K | 117K | 796K | -879K | 273K | 193K |
Operating Cash Flow | -14.92M | -16.48M | -16.19M | -13.69M | -15.6M | -14.2M | -16.23M | -22.46M | -20.64M | -21.43M | -19.46M | -15.96M | -14.86M | -12.72M | -12.18M | -9.84M | -9.41M |
Capital Expenditures | 0.00 | -8K | -65.01K | -66.49K | -80.55K | -117.55K | -72.54K | -133K | -119K | -74K | -70K | -12K | -27K | -52K | -45K | -60K | -172K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 0.00 | -8K | -65.01K | -66.49K | -80.55K | -117.55K | -72.54K | -133K | -119K | -74K | -70K | -12K | -27K | -52K | -45K | -60K | -172K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | -7K | -14K | -21K | -28K | -27K | -29K | -33K | -36K | -39K | -41K | -39K | -73K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 306.00 | 306.00 | 4M | 4M | 4M | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | n/a | -174.37K | -69.9K | -65.9K | -65.91K | 101.46K | -10.01K | -21.01K | -27K | -29K | -33K | 36.4M | 38.47M | 42.09M | 57.64M | 21.18M |
Net Cash Flow | -14.92M | -16.49M | -16.72M | -14.28M | -12.14M | -10.79M | -12.32M | -18.61M | -20.78M | -21.54M | -19.56M | -16M | 21.51M | 25.7M | 29.86M | 47.75M | 11.59M |
Free Cash Flow | -14.92M | -16.49M | -16.25M | -13.81M | -15.68M | -14.32M | -16.31M | -22.59M | -20.75M | -21.51M | -19.53M | -15.97M | -14.89M | -12.77M | -12.22M | -9.9M | -9.58M |